The St.Emlyn’s Podcast

Helping Children Understand Tragedy: Guidance for Parents and Professionals

In a recent St Emlyn's podcast, Iain Beardsell and Liz Crowe, an advanced social worker in a pediatric intensive care unit in Brisbane, explored the critical topic of how to communicate with children during tragic situations. The discussion emphasized the importance of honesty and directness when dealing with topics like illness, death, and other forms of hardship.

Understanding the Context

Historically, children in many cultures were more regularly exposed to the realities of life, such as birth and death. In contrast, modern Western societies often shield children from these experiences. However, Liz asserts that children are more perceptive and resilient than we give them credit for, and attempts to protect them from all emotional pain can be detrimental. Shielding children from the truth can lead to confusion and increased anxiety, as they often sense when something is wrong, even if it is not explicitly communicated to them.

The Importance of Honesty

When difficult situations arise, such as a family member being diagnosed with a serious illness or being involved in an accident, adults may feel the instinct to protect children by withholding information. However, research and experience show that children cope better when they are informed and involved. Children, especially those under ten, can mistakenly believe they are responsible for negative events due to their egocentric worldview. Therefore, it is crucial to communicate clearly and truthfully, helping them understand the situation without assigning blame to themselves.

Balancing Protection and Reality

Parents naturally want to protect their children from pain. However, overprotection can prevent children from learning to deal with disappointment and hardship, essential components of developing resilience. Liz argues that by being overly protective, we may contribute to rising rates of depression and mental health issues among young people. It's essential to prepare children for life's challenges by allowing them to experience and understand difficult emotions in a supportive environment.

Practical Approaches to Communication

When faced with the need to communicate difficult news to children, it's important to empower familiar adults—such as parents or guardians—to have these conversations rather than leaving them to strangers. Here’s a suggested approach:

1. Preparation: Prepare the adults involved in the child's life by discussing the importance of honest communication and the possible impacts of the conversation.

Using Accurate Language

It’s crucial to use accurate language when discussing severe issues. Avoid using vague terms like "poorly," which can lead to misunderstandings. For example, describing a child as "very sick" without specifying the illness can cause confusion and fear, especially if the child later associates the term with less severe conditions. Using specific medical terminology helps children differentiate between different types of illnesses and their severity.

Long-Term Impact on Children

Many parents and caregivers worry that exposure to tragedy will permanently damage their children. While such experiences can indeed be life-changing, they do not necessarily result in negative outcomes. Children who experience the death of a sibling or parent may grieve and feel pain, but they can also develop greater empathy and understanding of life's complexities. Research indicates that while children in these situations may have higher levels of anxiety, they are not necessarily less successful academically or socially. They often develop a deeper sensitivity and a better understanding of life.

The Role of Counseling and Support

While counseling can be helpful, Liz cautions against making it the default response. Instead, she suggests that families should be encouraged to navigate these challenges on their own, seeking professional help only if they find themselves unable to cope. This approach fosters resilience and self-reliance, teaching children that while therapy is a valuable resource, it's not always necessary.

Conclusion: Building Resilience

Ultimately, difficult conversations with children about tragedy are a necessary part of life. By approaching these conversations with honesty, clarity, and support, we can help children navigate their emotions and develop the resilience needed for future challenges. Whether as parents or healthcare professionals, our role is to guide children through these experiences, providing the tools and understanding they need to grow and thrive.

At St Emlyn's, we believe that while we can't shield children from all of life's difficulties, we can help them face these challenges with courage. The experiences that children go through, even the painful ones, can serve as opportunities for growth and learning. With the right support, children can emerge from these experiences stronger and better equipped to handle life's complexities. Our goal is to create a safe space for children to express their feelings, ask questions, and ultimately, develop the resilience they need to navigate the ups and downs of life

Helping Children Understand Tragedy: Guidance for Parents and Professionals

In a recent St Emlyn's podcast, Iain Beardsell and Liz Crowe, an advanced social worker in a pediatric intensive care unit in Brisbane, explored the critical topic of how to communicate with children during tragic situations. The discussion emphasized the importance of honesty and directness when dealing with topics like illness, death, and other forms of hardship.

Understanding the Context

Historically, children in many cultures were more regularly exposed to the realities of life, such as birth and death. In contrast, modern Western societies often shield children from these experiences. However, Liz asserts that children are more perceptive and resilient than we give them credit for, and attempts to protect them from all emotional pain can be detrimental. Shielding children from the truth can lead to confusion and increased anxiety, as they often sense when something is wrong, even if it is not explicitly communicated to them.

The Importance of Honesty

When difficult situations arise, such as a family member being diagnosed with a serious illness or being involved in an accident, adults may feel the instinct to protect children by withholding information. However, research and experience show that children cope better when they are informed and involved. Children, especially those under ten, can mistakenly believe they are responsible for negative events due to their egocentric worldview. Therefore, it is crucial to communicate clearly and truthfully, helping them understand the situation without assigning blame to themselves.

Balancing Protection and Reality

Parents naturally want to protect their children from pain. However, overprotection can prevent children from learning to deal with disappointment and hardship, essential components of developing resilience. Liz argues that by being overly protective, we may contribute to rising rates of depression and mental health issues among young people. It's essential to prepare children for life's challenges by allowing them to experience and understand difficult emotions in a supportive environment.

Practical Approaches to Communication

When faced with the need to communicate difficult news to children, it's important to empower familiar adults—such as parents or guardians—to have these conversations rather than leaving them to strangers. Here’s a suggested approach:

1. Preparation: Prepare the adults involved in the child's life by discussing the importance of honest communication and the possible impacts of the conversation.

Using Accurate Language

It’s crucial to use accurate language when discussing severe issues. Avoid using vague terms like "poorly," which can lead to misunderstandings. For example, describing a child as "very sick" without specifying the illness can cause confusion and fear, especially if the child later associates the term with less severe conditions. Using specific medical terminology helps children differentiate between different types of illnesses and their severity.

Long-Term Impact on Children

Many parents and caregivers worry that exposure to tragedy will permanently damage their children. While such experiences can indeed be life-changing, they do not necessarily result in negative outcomes. Children who experience the death of a sibling or parent may grieve and feel pain, but they can also develop greater empathy and understanding of life's complexities. Research indicates that while children in these situations may have higher levels of anxiety, they are not necessarily less successful academically or socially. They often develop a deeper sensitivity and a better understanding of life.

The Role of Counseling and Support

While counseling can be helpful, Liz cautions against making it the default response. Instead, she suggests that families should be encouraged to navigate these challenges on their own, seeking professional help only if they find themselves unable to cope. This approach fosters resilience and self-reliance, teaching children that while therapy is a valuable resource, it's not always necessary.

Conclusion: Building Resilience

Ultimately, difficult conversations with children about tragedy are a necessary part of life. By approaching these conversations with honesty, clarity, and support, we can help children navigate their emotions and develop the resilience needed for future challenges. Whether as parents or healthcare professionals, our role is to guide children through these experiences, providing the tools and understanding they need to grow and thrive.

At St Emlyn's, we believe that while we can't shield children from all of life's difficulties, we can help them face these challenges with courage. The experiences that children go through, even the painful ones, can serve as opportunities for growth and learning. With the right support, children can emerge from these experiences stronger and better equipped to handle life's complexities. Our goal is to create a safe space for children to express their feelings, ask questions, and ultimately, develop the resilience they need to navigate the ups and downs of life

Introduction

Selection bias is a critical issue in medical research that can undermine the validity of study findings. It occurs when there is a systematic difference between the study population and the broader population the research aims to represent. Understanding selection bias is essential for clinicians and researchers, as it can lead to questionable conclusions and affect clinical practice. This summary covers the definition of selection bias, its sources, and ways to mitigate it, along with a case study illustrating its impact.

What is Selection Bias?

Selection bias happens when the participants in a study do not accurately reflect the general population. This discrepancy can result from various factors, including how patients are selected, the setting of the study, and the timing of patient recruitment. Such biases can skew research results, making them less applicable to real-world situations. As medical professionals rely heavily on research to inform clinical decisions, recognizing and addressing selection bias is crucial.

Sources of Selection Bias

Study Environment

The environment where a study is conducted can significantly influence patient selection. For instance, patients in a general practitioner's office might have a lower prevalence of serious conditions compared to those in an emergency department. Additionally, studies in specialized tertiary care centers often include patients with more severe or rare conditions, which may not represent the general patient population. This can lead to overestimating or underestimating the effectiveness of treatments or the accuracy of diagnostic tests.

Timing of Patient Recruitment

The timing of patient recruitment is another source of selection bias. The stage of illness at which patients are recruited can affect study outcomes, especially in diagnostic studies. For example, the diagnostic value of CRP for appendicitis changes depending on when it is measured. Additionally, certain conditions may present differently depending on the time of day or week, potentially leading to an incomplete understanding of a condition's prevalence or severity if the study only includes patients from specific times.

Retrospective vs. Prospective Studies

Retrospective studies, which rely on historical data, are particularly vulnerable to selection bias. These studies may selectively include data from periods with better patient outcomes, leading to skewed results. They may also suffer from incomplete data or changes in diagnostic criteria over time, making it difficult to generalize findings. Prospective studies, while more controlled, also need careful planning to avoid selection bias, especially in defining inclusion and exclusion criteria.

Convenience Sampling

Convenience sampling involves selecting patients based on availability rather than a structured protocol, often due to resource limitations. This can result in a non-representative sample, such as including only daytime patients who might differ from those presenting at night. While convenience sampling can be a pragmatic choice, it often leads to underrepresentation of certain patient groups, potentially biasing study findings.

Mitigating Selection Bias

To mitigate selection bias, researchers should strive for comprehensive sampling strategies, such as random or consecutive sampling. Where complete sampling is not possible, they should transparently report potential biases and the measures taken to minimize them. For instance, using screening logs or adjusting for demographic differences can help address disparities between recruited and non-recruited patients. Sensitivity analyses can also be used to understand the impact of excluding certain patient groups.

Case Study: Thrombolysis in PEA Cardiac Arrest

A recent journal club discussion highlighted a retrospective cohort study by Shereefi et al., examining the efficacy of half-dose thrombolysis in patients with PEA cardiac arrest and confirmed pulmonary embolism (PE). The study raised concerns due to several potential biases. The arbitrary selection of a 23-month inclusion period, without a clear rationale, suggests the possibility of survival bias, as it included only patients who survived long enough to receive a confirmatory diagnosis of PE. This selective inclusion means the findings might overestimate the treatment's effectiveness, as the study only considered patients with a relatively favorable prognosis.

Moreover, the study's setting in a specialized environment and the inclusion of only confirmed PE cases limit the generalizability of the results. In practice, thrombolysis may be administered based on clinical suspicion rather than confirmed diagnosis, which involves a broader and potentially more diverse patient group. The study's focus on survivors also excludes those who may have died before a diagnosis, further skewing the data towards more favorable outcomes.

Implications of Selection Bias

Selection bias can significantly impact the interpretation of study results and, consequently, clinical decisions. It can lead to over- or underestimation of a treatment's effectiveness or the prevalence of a condition. This bias can also affect healthcare policy and practice guidelines, potentially disadvantaging underrepresented patient groups. For example, guidelines developed from biased research may fail to address the needs of older adults or those with comorbidities if these groups are underrepresented in studies.

Conclusion

Selection bias is a pervasive issue that can undermine the credibility of medical research. It arises from various sources, including the study environment, timing of recruitment, study design, and sampling methods. While complete elimination of selection bias is challenging, awareness and careful methodological design can mitigate its effects. Researchers and clinicians must critically appraise studies, considering potential biases and their implications for clinical practice. By doing so, we can make more informed decisions and improve patient care. At St. Emlyns, we continue to explore these critical appraisal topics to support evidence-based practice.

Upper gastrointestinal (GI) bleeding is a common and potentially life-threatening condition encountered in emergency medicine. It encompasses a broad spectrum of clinical presentations, ranging from mild cases with minimal blood loss to severe, life-threatening hemorrhages. Understanding the various causes, accurate risk stratification, and appropriate management strategies are crucial for optimizing patient outcomes.

Upper GI bleeding originates from the upper part of the gastrointestinal tract, including the esophagus, stomach, and the duodenum. Common causes include:

1. Mallory-Weiss Tears: These are tears at the gastroesophageal junction caused by forceful vomiting or retching.

It is also important to distinguish true upper GI bleeding from conditions that mimic it. For example, blood from a nosebleed (epistaxis) may be swallowed and later vomited, simulating GI bleeding. Additionally, differentiating between hemoptysis (coughing up blood) and hematemesis (vomiting blood) is essential for accurate diagnosis.

Effective management of upper GI bleeding begins with risk stratification to determine the severity of the condition and the need for urgent intervention. The Glasgow-Blatchford Score (GBS) is a widely utilized tool that helps predict the need for medical treatment and the risk of adverse outcomes. It considers several clinical parameters, including:

• Blood Urea Nitrogen (BUN): Elevated levels suggest significant bleeding.

Patients with a GBS of zero are considered low risk and may be suitable for outpatient management with appropriate follow-up. Those with higher scores require hospitalization for further evaluation and treatment, including possible endoscopy.

The immediate management of patients with upper GI bleeding involves stabilizing the patient and preventing further complications. Key steps include:

1. Airway Management: Ensuring a clear and secure airway is critical, particularly in patients with altered consciousness or ongoing vomiting.

Endoscopy is a crucial diagnostic and therapeutic tool in managing upper GI bleeding. It should ideally be performed within 24 hours of presentation to determine the source of bleeding and provide treatment. Urgent endoscopy is particularly indicated for patients with hemodynamic instability or signs of significant bleeding.

Variceal bleeding, often seen in patients with chronic liver disease, requires specific management strategies due to its severity and associated complications. Key considerations include:

• Terlipressin: A vasoconstrictor that helps reduce portal pressure and control bleeding in variceal cases.

The management of upper GI bleeding, particularly severe cases, requires a coordinated approach involving multiple specialties. The emergency physician plays a central role in initial stabilization and diagnosis, but collaboration with gastroenterologists, anesthetists, hematologists, and critical care teams is essential. This multidisciplinary team ensures comprehensive care, from initial resuscitation and endoscopic intervention to ongoing monitoring and treatment in critical care settings.

The decision to admit or discharge a patient with upper GI bleeding depends on the severity of the bleeding, patient stability, and the results of risk stratification. Low-risk patients (GBS of zero) may be discharged with a plan for outpatient follow-up and endoscopy. In contrast, patients with higher risk scores or ongoing symptoms should be admitted for further evaluation and treatment.

Upper GI bleeding is a critical condition that demands prompt recognition, accurate assessment, and effective management. By utilizing risk stratification tools like the Glasgow-Blatchford Score and employing a multidisciplinary approach, healthcare providers can significantly improve patient outcomes. Proper diagnosis and timely intervention, including endoscopy and appropriate supportive care, are vital components of successful management.

As always, we encourage healthcare professionals to share their experiences and best practices in managing upper GI bleeds. Engage with us on social media or leave a comment on this blog post to contribute to the ongoing discussion on improving emergency medicine care.

Understanding Blinding in Clinical Trials: A Comprehensive Guide

Blinding, also referred to as masking, is a crucial methodological approach used in clinical trials to eliminate bias and ensure the validity of study outcomes. This practice involves keeping study participants, clinicians, and researchers unaware of the treatment assignments. The goal is to prevent the knowledge of treatment allocation from influencing behaviors, perceptions, or evaluations, thus maintaining the integrity of the research.

Single Blinding: In this approach, only the participants are unaware of the treatment they receive. For example, in a drug trial comparing an anticoagulant to a placebo, participants do not know which they are receiving. This method helps prevent the placebo effect or other biases arising from participants' expectations. Ensuring effective single blinding requires that the placebo and active treatment appear identical in all sensory aspects, including appearance, taste, and even side effects.

Double Blinding: This method extends the concealment to both participants and the clinicians or researchers administering the treatment. It is crucial because knowledge of the treatment can influence the clinical management of the patient or the interpretation of symptoms. For example, if a doctor knows a patient is receiving a placebo, they might provide less attentive care. Double blinding helps ensure that all patients receive consistent care, and it prevents clinicians from unintentionally influencing the outcomes based on their expectations.

Triple Blinding: The most comprehensive form of blinding, triple blinding, includes blinding the data analysts as well. This method prevents bias during the interpretation of study results, as analysts are unaware of which group received the treatment. This approach is particularly important when the data analysis involves subjective judgments or when the analysis plan is not strictly predefined. Triple blinding helps ensure that data is handled objectively, leading to more reliable conclusions.

Blinding is essential to minimize various forms of bias that can compromise the validity of clinical trials. These biases include:

Participant Bias: When participants know the treatment they are receiving, it can influence their reporting of symptoms and outcomes, skewing the study results.

Observer Bias: Clinicians and researchers may consciously or unconsciously alter their assessments based on their knowledge of the treatment allocation. This can affect how symptoms are recorded or how interventions are implemented, potentially leading to biased outcomes.

Analyst Bias: Data analysts may be influenced by their expectations or hypotheses if they know which treatment group participants belong to. This can affect the objectivity of the data analysis, making the results less reliable.

Despite its importance, blinding is not always feasible or ethical in all types of studies. For example, in trials comparing physical interventions like a wrist splint versus a plaster cast, it is impossible to blind participants or clinicians due to the visible nature of the treatments. In such cases, researchers must adopt a pragmatic approach, using rigorous randomization and transparent reporting to mitigate potential biases.

A notable case highlighting the challenges of blinding is a study conducted by Dan Horner and colleagues on the treatment of calf deep vein thrombosis (DVT). The study compared the use of warfarin with no anticoagulation. Ideally, the study would have included a placebo group, but ethical and practical concerns made this impossible. Patients on warfarin require regular monitoring and dose adjustments, which could not ethically be simulated for a placebo group. As a result, the study was conducted without blinding but still provided valuable insights into the treatment's potential benefits.

In some studies, particularly those involving surgical procedures, sham interventions are used to maintain blinding. This involves performing procedures on the control group that mimic the intervention without providing therapeutic benefits. For instance, in trials assessing surgical techniques, control group participants might undergo anesthesia and incision without actual surgery. This method is ethically sensitive but can be crucial in preventing bias from influencing the study's outcomes.

Blinding is also vital in diagnostic studies, where it ensures that the assessment of diagnostic tests is not influenced by pre-existing knowledge about the patients. For instance, in evaluating a new diagnostic test like a D-dimer test for pulmonary embolism, blinding the interpreters of test results is essential. It prevents bias in the interpretation of test outcomes, ensuring that results are evaluated based on the test's performance rather than expectations or assumptions.

Blinding is a fundamental component of clinical trial design, crucial for minimizing bias and ensuring the validity of study findings. Whether it is single, double, or triple blinding, the technique helps maintain objectivity in clinical research, making the results more reliable and trustworthy. While blinding is not always possible, especially in trials involving visible interventions, researchers must strive to minimize bias through careful study design and transparent reporting.

As readers and critical appraisers of clinical research, it is essential to look for evidence of blinding and consider its impact on the validity of study results. Understanding the importance and challenges of blinding can help us better interpret clinical trial outcomes and make informed decisions in healthcare.

Thank you for joining us at St. Emlyn's. Stay curious, critically appraise the evidence, and continue exploring the fascinating world of clinical trials. Until next time, stay informed and engaged in advancing medical knowledge.